A detailed history of Neos Investment Management LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 46,815 shares of COGT stock, worth $363,284. This represents 0.02% of its overall portfolio holdings.

Number of Shares
46,815
Previous 43,856 6.75%
Holding current value
$363,284
Previous $370 Million 36.76%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.24 - $11.48 $24,382 - $33,969
2,959 Added 6.75%
46,815 $506 Million
Q2 2024

Aug 14, 2024

BUY
$6.01 - $9.04 $153,585 - $231,017
25,555 Added 139.64%
43,856 $370 Million
Q1 2024

May 13, 2024

BUY
$4.38 - $9.02 $23,498 - $48,392
5,365 Added 41.47%
18,301 $123 Million
Q4 2023

Feb 13, 2024

BUY
$4.06 - $10.08 $52,520 - $130,394
12,936 New
12,936 $76.1 Million

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $510M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.